Phylogeny  
PAK2 is a Group I p21-activated kinase within the STE20 branch of the human kinome (chetty2022rhofamilygtpase pages 3-4).  
Orthologs are documented in Mus musculus (Pak2), Danio rerio (pak2), Drosophila melanogaster (Pak), Caenorhabditis elegans (pak-1) and Saccharomyces cerevisiae (Ste20) (kumar2017structurebiochemistryand pages 1-3).  
Mammalian PAK2 can replace yeast Ste20 in functional complementation assays, underscoring deep evolutionary conservation (arias‐romero2008ataleof pages 1-3).  
Sequence identity exceeds 88 % in the CRIB domain and 93 % in the catalytic domain when compared with PAK1 and PAK3 (arias‐romero2008ataleof pages 1-3).  

Reaction Catalyzed  
ATP + protein-Ser/Thr → ADP + protein-O-phospho-Ser/Thr (zhao2012pakfamilykinases pages 1-3).  

Cofactor Requirements  
Catalytic activity is dependent on divalent metal ions, with Mg²⁺ or Mn²⁺ required in vitro (huang2020pak2activatedby pages 12-12).  

Substrate Specificity  
Type I PAKs, including PAK2, preferentially phosphorylate serine residues preceded by Arg at −2, another basic residue at −3 and followed by a hydrophobic residue at +1, with larger hydrophobes favoured at +2/+3 (chetty2022rhofamilygtpase pages 3-4).  
This specificity arises from electrostatic pairing of substrate arginines with an acidic pocket adjacent to the catalytic cleft (chetty2022rhofamilygtpase pages 22-25).  

Structure  
PAK2 comprises an N-terminal basic segment (1–69), a CDC42/RAC1 interactive binding (CRIB) domain 70–113 overlapping an autoinhibitory domain (AID) 83–149, proline-rich SH3-binding motifs ~150–250 and a C-terminal kinase domain 282–524 (arias‐romero2008ataleof pages 1-3).  
The crystal structure of the kinase domain (PDB 6C5R) and the AlphaFold model AF-Q13177-F1 display a canonical bilobal fold with a conserved Lys-Glu ion pair, correctly positioned αC-helix, DFG-in activation loop and an intact hydrophobic spine (huang2020pak2activatedby pages 12-12).  
Inactive PAK2 forms a trans-autoinhibited dimer in which the AID of one protomer occupies the catalytic cleft of its partner (grebenova2019pak1pak1δ15and pages 1-2).  
Autophosphorylation at Ser141 disengages the AID, stabilising the active conformation (grebenova2019pak1pak1δ15and pages 1-2).  
Thr402 within the activation loop is a secondary autophosphorylation site that maximises catalytic efficiency (kumar2017structurebiochemistryand pages 25-29).  
A flexible inter-domain linker permits the large conformational changes required for dimer dissociation upon activation (chetty2022rhofamilygtpase pages 15-17).  

Regulation  
Binding of GTP-loaded CDC42 or RAC1 to the CRIB domain disrupts the autoinhibited dimer and initiates activation-loop autophosphorylation (chetty2022rhofamilygtpase pages 3-4).  
Ser141 autophosphorylation is the principal activation switch (grebenova2019pak1pak1δ15and pages 1-2).  
Thr402 autophosphorylation further enhances enzymatic turnover (kumar2017structurebiochemistryand pages 25-29).  
Additional regulatory sites such as Ser20 and Ser197 are phosphorylated by kinases including PDK1 and AKT and dephosphorylated by PP2A (huang2020pak2activatedby pages 12-12).  
Caspase-3 cleavage at Asp212 during apoptosis generates a constitutively active 34 kDa fragment that amplifies death signalling (grebenova2019pak1pak1δ15and pages 16-17).  
MicroRNAs miR-23b and miR-137 repress PAK2 translation, adding a layer of post-transcriptional control (kumar2017structurebiochemistryand pages 9-11).  

Function  
PAK2 is ubiquitously expressed with highest levels in spleen, thymus and fetal brain (huang2020pak2activatedby pages 12-12).  
Pak2 knockout in mice is embryonic lethal, highlighting its essential developmental role (kumar2017structurebiochemistryand pages 9-11).  
Full-length PAK2 promotes survival and motility by phosphorylating MAPK4 and MAPK6, which activate MAPKAPK5 to drive F-actin assembly (huang2020pak2activatedby pages 12-12).  
Phosphorylation of JUN by PAK2 supports EGF-stimulated proliferation (huang2020pak2activatedby pages 12-12).  
Cytoskeletal remodelling involves phosphorylation of LIMK1, histone H4, merlin and paxillin, modulating actin dynamics and adhesion (grebenova2019pak1pak1δ15and pages 1-2).  
Direct phosphorylation of caspase-7 by PAK2 dampens chemotherapy-induced apoptosis (grebenova2019pak1pak1δ15and pages 16-17).  
External stimuli such as transforming growth factor-β, hyperosmotic shock, UV light and ionising radiation activate PAK2 via GTPase-dependent or caspase-dependent mechanisms (grebenova2019pak1pak1δ15and pages 16-17).  
Insulin signalling inhibits PAK2, facilitating GLUT4 translocation in neurons and linking the kinase to metabolic control (kumar2017structurebiochemistryand pages 9-11).  
Proline-rich motifs recruit PIX adaptors to assemble RAC1 activation complexes, conferring spatial specificity to PAK2 signalling (dobrigna2023themolecularbasis pages 6-7).  

Inhibitors  
IPA-3 is a covalent allosteric inhibitor targeting the regulatory domain with sub-micromolar potency against PAK2 (grebenova2019pak1pak1δ15and pages 1-2).  
FRAX597 is an ATP-competitive inhibitor that efficiently suppresses PAK2 catalytic activity (grebenova2019pak1pak1δ15and pages 1-2).  
PF-3758309, G-5555 and KPT-9274 are additional small-molecule inhibitors displaying nanomolar activity toward Group I PAKs, including PAK2 (chetty2022rhofamilygtpase pages 22-25).  
A PAK1-selective degrader described by Chow et al. showed limited cross-degradation of PAK2, illustrating avenues for isoform selectivity (chow2022developmentandutility pages 27-28).  

Other Comments  
Monoallelic loss-of-function variants such as p.Glu435Lys in PAK2 cause Knobloch syndrome-2 and related neurodevelopmental disorders by haploinsufficiency (dobrigna2023themolecularbasis pages 6-7).  
The p.Glu435Lys mutation is also observed in cancers and perturbs kinase activity and protein interactions, implicating PAK2 in oncogenesis (grebenova2019pak1pak1δ15and pages 1-2).  
Overexpression or hyperactivation of PAK2 drives cellular motility, invasion and chemoresistance in diverse tumour contexts (kumar2017structurebiochemistryand pages 25-29).

References

1. (grebenova2019pak1pak1δ15and pages 1-2): D. Grebeňová, A. Holoubek, P. Röselová, A. Obr, B. Brodská, and K. Kuželová. Pak1, pak1δ15, and pak2: similarities, differences and mutual interactions. Scientific Reports, Mar 2019. URL: https://doi.org/10.1038/s41598-019-53665-6, doi:10.1038/s41598-019-53665-6. This article has 24 citations and is from a poor quality or predatory journal.

2. (huang2020pak2activatedby pages 12-12): J. Huang, Allen Huang, A. Poplawski, Frank DiPino, J. Traugh, and J. Ling. Pak2 activated by cdc42 and caspase 3 mediates different cellular responses to oxidative stress-induced apoptosis. Biochimica et biophysica acta. Molecular cell research, pages 118645, Jan 2020. URL: https://doi.org/10.1016/j.bbamcr.2020.118645, doi:10.1016/j.bbamcr.2020.118645. This article has 37 citations.

3. (kumar2017structurebiochemistryand pages 1-3): Rakesh Kumar, Rahul Sanawar, Xiaodong Li, and Feng Li. Structure, biochemistry, and biology of pak kinases. Gene, 605:20-31, Mar 2017. URL: https://doi.org/10.1016/j.gene.2016.12.014, doi:10.1016/j.gene.2016.12.014. This article has 236 citations and is from a peer-reviewed journal.

4. (arias‐romero2008ataleof pages 1-3): Luis E. Arias‐Romero and Jonathan Chernoff. A tale of two paks. Biology of the Cell, 100:97-108, Feb 2008. URL: https://doi.org/10.1042/bc20070109, doi:10.1042/bc20070109. This article has 421 citations and is from a peer-reviewed journal.

5. (chetty2022rhofamilygtpase pages 15-17): Ashwin K. Chetty, Byung Hak Ha, and Titus J. Boggon. Rho family gtpase signaling through type ii p21-activated kinases. Cellular and Molecular Life Sciences, Nov 2022. URL: https://doi.org/10.1007/s00018-022-04618-2, doi:10.1007/s00018-022-04618-2. This article has 20 citations and is from a domain leading peer-reviewed journal.

6. (dobrigna2023themolecularbasis pages 6-7): Manon Dobrigna, Sandrine Poëa-Guyon, Véronique Rousseau, Aline Vincent, Annick Toutain, and Jean-Vianney Barnier. The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: from genotype to phenotype. Frontiers in Neuroscience, Mar 2023. URL: https://doi.org/10.3389/fnins.2023.1123784, doi:10.3389/fnins.2023.1123784. This article has 10 citations and is from a peer-reviewed journal.

7. (grebenova2019pak1pak1δ15and pages 16-17): D. Grebeňová, A. Holoubek, P. Röselová, A. Obr, B. Brodská, and K. Kuželová. Pak1, pak1δ15, and pak2: similarities, differences and mutual interactions. Scientific Reports, Mar 2019. URL: https://doi.org/10.1038/s41598-019-53665-6, doi:10.1038/s41598-019-53665-6. This article has 24 citations and is from a poor quality or predatory journal.

8. (kumar2017structurebiochemistryand pages 25-29): Rakesh Kumar, Rahul Sanawar, Xiaodong Li, and Feng Li. Structure, biochemistry, and biology of pak kinases. Gene, 605:20-31, Mar 2017. URL: https://doi.org/10.1016/j.gene.2016.12.014, doi:10.1016/j.gene.2016.12.014. This article has 236 citations and is from a peer-reviewed journal.

9. (chetty2022rhofamilygtpase pages 22-25): Ashwin K. Chetty, Byung Hak Ha, and Titus J. Boggon. Rho family gtpase signaling through type ii p21-activated kinases. Cellular and Molecular Life Sciences, Nov 2022. URL: https://doi.org/10.1007/s00018-022-04618-2, doi:10.1007/s00018-022-04618-2. This article has 20 citations and is from a domain leading peer-reviewed journal.

10. (chetty2022rhofamilygtpase pages 3-4): Ashwin K. Chetty, Byung Hak Ha, and Titus J. Boggon. Rho family gtpase signaling through type ii p21-activated kinases. Cellular and Molecular Life Sciences, Nov 2022. URL: https://doi.org/10.1007/s00018-022-04618-2, doi:10.1007/s00018-022-04618-2. This article has 20 citations and is from a domain leading peer-reviewed journal.

11. (chow2022developmentandutility pages 27-28): Hoi-Yee Chow, Sofiia Karchugina, Brian J. Groendyke, Sean Toenjes, John Hatcher, Katherine A. Donovan, Eric S. Fischer, Gleb Abalakov, Bulat Faezov, Roland Dunbrack, Nathanael S. Gray, and Jonathan Chernoff. Development and utility of a pak1-selective degrader. Journal of Medicinal Chemistry, 65:15627-15641, Nov 2022. URL: https://doi.org/10.1021/acs.jmedchem.2c00756, doi:10.1021/acs.jmedchem.2c00756. This article has 17 citations and is from a highest quality peer-reviewed journal.

12. (kumar2017structurebiochemistryand pages 9-11): Rakesh Kumar, Rahul Sanawar, Xiaodong Li, and Feng Li. Structure, biochemistry, and biology of pak kinases. Gene, 605:20-31, Mar 2017. URL: https://doi.org/10.1016/j.gene.2016.12.014, doi:10.1016/j.gene.2016.12.014. This article has 236 citations and is from a peer-reviewed journal.

13. (zhao2012pakfamilykinases pages 1-3): Zhuo-shen Zhao and E. Manser. Pak family kinases. Cellular Logistics, 2:59-68, Apr 2012. URL: https://doi.org/10.4161/cl.21912, doi:10.4161/cl.21912. This article has 138 citations.
